{
  "report_rows": [
    {
      "kpi": "Operating EPS (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$2.29 vs. cons $2.25",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Net sales (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$6.38B vs. cons $6.31B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth (Q2 2026)",
      "prediction": "BEAT",
      "answer": "pred ~3.6% vs. cons 3.22%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Organic sales growth (FY 2026)",
      "prediction": "BETTER",
      "answer": "guide ~3.2% vs. cons 2.97%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Operating EPS (FY 2026)",
      "prediction": "UNCHANGED",
      "answer": "guide ~$8.65-$8.80 vs. cons $8.75",
      "confidence": "LOW"
    },
    {
      "kpi": "Organic sales growth (Q3 2026)",
      "prediction": "BETTER",
      "answer": "guide ~3.6% vs. cons 3.45%",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": 5.0,
  "day1_confidence": "LOW",
  "day5_residual_pct": 6.0,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "FOLLOW-THROUGH \u2014 estimate upgrades should follow a real contingency release and stronger organic-growth outlook.",
  "day5_confidence": "LOW"
}